| Dr Stephen Michael Szirovecz, OD | |
|
1114 Northpoint Cir, Alpharetta, GA 30022-4854 | |
| (770) 667-8060 | |
| (770) 667-2024 |
| Full Name | Dr Stephen Michael Szirovecz |
|---|---|
| Gender | Male |
| Speciality | Optometry |
| Experience | 32 Years |
| Location | 1114 Northpoint Cir, Alpharetta, Georgia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1487826988 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 1353 (Georgia) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Optima Eye Care Llc | 6103215801 | 3 |
| Myeyedr Optometry Of Georgia, Llc | 8224261201 | 79 |
News Archive
The Michael J. Fox Foundation for Parkinson's Research today announced nearly $1.1 million for projects aimed at advancing the development of leading biomarker candidates for Parkinson's disease. The discovery and validation of biomarkers is of critical importance to increasing the speed and efficiency of PD therapeutic development, allowing scientists and clinicians to more accurately identify appropriate subjects for clinical studies, measure disease progression and monitor treatment effects in clinical trials.
Parents, doctors, and others have wondered whether common treatments for attention-deficit hyperactivity disorder (ADHD) inadvertently predispose adolescents to future drug abuse.
Black children with chronic kidney disease have more severe anemia than white children even when they receive the same treatment, according to a multicenter study led by Johns Hopkins Children's Center to be published in the May issue of the American Journal of Kidney Disease.
Nearly half of all U.S. adults say they can't live without their smartphones, according to the Pew Research Center. But what happens when our fondness for the latest electronic gadgets creates more pain than gain?
Verastem, Inc., a clinical-stage biopharmaceutical company focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells, announced the initiation of a Phase 1/1b trial of VS-6063 in combination with paclitaxel for the treatment of advanced ovarian cancer.
› Verified 7 days ago
| Provider Name | Myeyedr Optometry Of Georgia, Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1437294592 PECOS PAC ID: 8224261201 Enrollment ID: O20140428000739 |
News Archive
The Michael J. Fox Foundation for Parkinson's Research today announced nearly $1.1 million for projects aimed at advancing the development of leading biomarker candidates for Parkinson's disease. The discovery and validation of biomarkers is of critical importance to increasing the speed and efficiency of PD therapeutic development, allowing scientists and clinicians to more accurately identify appropriate subjects for clinical studies, measure disease progression and monitor treatment effects in clinical trials.
Parents, doctors, and others have wondered whether common treatments for attention-deficit hyperactivity disorder (ADHD) inadvertently predispose adolescents to future drug abuse.
Black children with chronic kidney disease have more severe anemia than white children even when they receive the same treatment, according to a multicenter study led by Johns Hopkins Children's Center to be published in the May issue of the American Journal of Kidney Disease.
Nearly half of all U.S. adults say they can't live without their smartphones, according to the Pew Research Center. But what happens when our fondness for the latest electronic gadgets creates more pain than gain?
Verastem, Inc., a clinical-stage biopharmaceutical company focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells, announced the initiation of a Phase 1/1b trial of VS-6063 in combination with paclitaxel for the treatment of advanced ovarian cancer.
› Verified 7 days ago
| Provider Name | Optima Eye Care Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1689130874 PECOS PAC ID: 6103215801 Enrollment ID: O20211118002283 |
News Archive
The Michael J. Fox Foundation for Parkinson's Research today announced nearly $1.1 million for projects aimed at advancing the development of leading biomarker candidates for Parkinson's disease. The discovery and validation of biomarkers is of critical importance to increasing the speed and efficiency of PD therapeutic development, allowing scientists and clinicians to more accurately identify appropriate subjects for clinical studies, measure disease progression and monitor treatment effects in clinical trials.
Parents, doctors, and others have wondered whether common treatments for attention-deficit hyperactivity disorder (ADHD) inadvertently predispose adolescents to future drug abuse.
Black children with chronic kidney disease have more severe anemia than white children even when they receive the same treatment, according to a multicenter study led by Johns Hopkins Children's Center to be published in the May issue of the American Journal of Kidney Disease.
Nearly half of all U.S. adults say they can't live without their smartphones, according to the Pew Research Center. But what happens when our fondness for the latest electronic gadgets creates more pain than gain?
Verastem, Inc., a clinical-stage biopharmaceutical company focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells, announced the initiation of a Phase 1/1b trial of VS-6063 in combination with paclitaxel for the treatment of advanced ovarian cancer.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Stephen Michael Szirovecz, OD 1114 Northpoint Cir, Alpharetta, GA 30022-4854 Ph: (770) 667-8060 | Dr Stephen Michael Szirovecz, OD 1114 Northpoint Cir, Alpharetta, GA 30022-4854 Ph: (770) 667-8060 |
News Archive
The Michael J. Fox Foundation for Parkinson's Research today announced nearly $1.1 million for projects aimed at advancing the development of leading biomarker candidates for Parkinson's disease. The discovery and validation of biomarkers is of critical importance to increasing the speed and efficiency of PD therapeutic development, allowing scientists and clinicians to more accurately identify appropriate subjects for clinical studies, measure disease progression and monitor treatment effects in clinical trials.
Parents, doctors, and others have wondered whether common treatments for attention-deficit hyperactivity disorder (ADHD) inadvertently predispose adolescents to future drug abuse.
Black children with chronic kidney disease have more severe anemia than white children even when they receive the same treatment, according to a multicenter study led by Johns Hopkins Children's Center to be published in the May issue of the American Journal of Kidney Disease.
Nearly half of all U.S. adults say they can't live without their smartphones, according to the Pew Research Center. But what happens when our fondness for the latest electronic gadgets creates more pain than gain?
Verastem, Inc., a clinical-stage biopharmaceutical company focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells, announced the initiation of a Phase 1/1b trial of VS-6063 in combination with paclitaxel for the treatment of advanced ovarian cancer.
› Verified 7 days ago
Dr. Kevin C. Peterson, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1845 Lockeway Dr, Suite 401, Alpharetta, GA 30004 Phone: 770-664-5580 | |
Windward Eye Care Optometrist Medicare: Medicare Enrolled Practice Location: 5315 Windward Pkwy, Suite F, Alpharetta, GA 30004 Phone: 678-393-2025 Fax: 678-393-0020 | |
Peachtree Eye Associates P C Optometrist Medicare: Medicare Enrolled Practice Location: 4190 Avalon Blvd Ste 4090, Alpharetta, GA 30009 Phone: 678-436-5145 Fax: 844-572-7904 | |
Eye Styles Llc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 5530 Windward Pkwy, Suite 1220, Alpharetta, GA 30004 Phone: 678-867-9868 | |
Eminence Family Eyecare, Llc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 6300 Atlanta Hwy # 9, Suite 101a, Alpharetta, GA 30004 Phone: 678-825-4077 | |
Dr. Susan Marie Reimbold, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 4180 Old Milton Pkwy, Suite 1-d, Alpharetta, GA 30005 Phone: 770-776-9000 | |
North Point Eye Care Optometrist Medicare: Not Enrolled in Medicare Practice Location: 5755 N Point Pkwy, Ste 222, Alpharetta, GA 30022 Phone: 770-410-1540 Fax: 770-410-7525 |